Here's Why Adaptive Biotechnologies Soared 61.7% in the First Half of 2020

Here's Why Adaptive Biotechnologies Soared 61.7% in the First Half of 2020

Investors expect the company's technology platform to come in handy as the world corrals the coronavirus pandemic.